oka
Start 7-day trial
Investor directory

Biotech & Pharma investors in Europe

410 funds · Sector

410 investors in the Oka directory for Europe name Biotech & Pharma as a focus. They back companies mainly at Seed, Series A and Series B and cluster in London, Paris and Amsterdam.

Showing 60 of 410 — those with the clearest Biotech & Pharma focus first.

Where these investors also appear

Seed investorsHealthTech investorsSeries A investorsSeries B investorsHardware investorsClimate investorsAI / ML investorsPre-Seed investorsInvestors in the United KingdomInvestors in GermanyInvestors in FranceInvestors in the Netherlands

Questions founders ask

Which Biotech & Pharma investors in Europe were most active in the last 12 months?
By funding rounds on record at Oka in the last 12 months: Creandum (19), Hitachi Ventures GmbH (11), Kima Ventures (11), Lifeline Ventures (11) and Plural (11). Counted from rounds reported in the press; unreported rounds are not included.
Which of these investors usually lead rounds?
Fund+ (led 10 of 11), Partech (led 10 of 15), SoftBank Vision Fund (led 10 of 15), Mercia Ventures (led 7 of 10) and Northern Gritstone (led 7 of 9) — counted over rounds in the last 24 months where the lead investor was reported.
At which stages do Biotech & Pharma investors in Europe invest?
Most often at Seed, Series A and Series B, by the stages these funds name on their profiles.
How many Biotech & Pharma investors in Europe does Oka list?
410 funds, as of October 2026.

Biotech & Pharma investors in Europe — which of them fit your round?

In 30 minutes you'll know which funds matter for your round.

Get a demo

Listed here and something is wrong? Tell us what to correct and we will update it — or ask us to remove the entry.